Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Management of externally manufactured cell therapy products: the Mayo Clinic approach.

Autor: Wiltshire TD; Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA., Deeds MC; Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA., Radel DJ; Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA., Bornschlegl AM; Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA., Schmidt CS; Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA., Thebiay JM; Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA., Pelleymounter LL; Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA., Jacob EK; Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA., Stubbs JR; Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA., Gastineau DA; Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA., Dietz AB; Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: dietz.allan@mayo.edu.

Publikováno v: Cytotherapy [Cytotherapy] 2022 Jan; Vol. 24 (1), pp. 19-26. Date of Electronic Publication: 2021 Jun 02.

Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.

Autor: Ji Y; Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA., Biernacka J, Snyder K, Drews M, Pelleymounter LL, Colby C, Wang L, Mrazek DA, Weinshilboum RM

Publikováno v: The pharmacogenomics journal [Pharmacogenomics J] 2012 Feb; Vol. 12 (1), pp. 78-85. Date of Electronic Publication: 2010 Sep 28.

Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomics.

Autor: Nordgren KK; Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Peng Y, Pelleymounter LL, Moon I, Abo R, Feng Q, Eckloff B, Yee VC, Wieben E, Weinshilboum RM

Publikováno v: Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2011 Nov; Vol. 39 (11), pp. 2135-47. Date of Electronic Publication: 2011 Aug 03.

CD38 expression, function, and gene resequencing in a human lymphoblastoid cell line-based model system.

Autor: Hartman WR; Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA., Pelleymounter LL, Moon I, Kalari K, Liu M, Wu TY, Escande C, Nin V, Chini EN, Weinshilboum RM

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2010 Jul; Vol. 51 (7), pp. 1315-25.